Bacterin Announces C
Bacterin Announces Clinical Results on the Use of OsteoSponge(R) SC Allograft Published in The Journal of Foot & Ankle Surgery
August 05, 2014 07:30 ET | Xtant Medical Holdings, Inc.
BELGRADE, Mont., Aug. 5, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE:BONE), a leader in the development of bone graft materials and bioactive coatings for medical...
Bacterin Announces P
Bacterin Announces Pricing of Public Offering of Common Stock
August 01, 2014 08:30 ET | Xtant Medical Holdings, Inc.
BELGRADE, Mont., Aug. 1, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today...
Bacterin Announces P
Bacterin Announces Public Offering of Common Stock
July 31, 2014 16:05 ET | Xtant Medical Holdings, Inc.
BELGRADE, Mont., July 31, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications,...
Bacterin to Report S
Bacterin to Report Second Quarter 2014 Financial Results on August 12, 2014
July 29, 2014 07:30 ET | Xtant Medical Holdings, Inc.
BELGRADE, Mont., July 29, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical...
Bacterin Announces R
Bacterin Announces Reverse Split of Common Stock
July 23, 2014 07:30 ET | Xtant Medical Holdings, Inc.
BELGRADE, Mont., July 23, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical...
Bacterin Announces P
Bacterin Announces Preliminary Second Quarter 2014 Results
July 21, 2014 17:53 ET | Xtant Medical Holdings, Inc.
Second Quarter total revenue expected to be in the range of $8.75 million to $8.85 million, an increase of approximately 6-7% over the same period last year. BELGRADE, Mont., July 21, 2014...
Bacterin Announces t
Bacterin Announces the Appointment of Robert Di Silvio as President
July 01, 2014 08:13 ET | Xtant Medical Holdings, Inc.
BELGRADE, Mont., July 1, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical...
Bacterin to Present
Bacterin to Present at the 2014 Newport Coast Securities, Inc. Annual Equity & National Sales Conference
June 10, 2014 14:38 ET | Xtant Medical Holdings, Inc.
BELGRADE, Mont., June 10, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts and coatings for medical...